DNUT Stock Cash Flow Statements

Krispy Kreme Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Krispy Kreme Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-29	2025-03-30	2024-12-29	2024-09-29	2024-06-30	2024-03-31	2023-12-31	2023-10-01	2023-07-02	2023-04-02	2023-01-01	2022-10-02	2022-07-03	2022-04-03	2022-01-02	2021-10-03

cash flows (used for)/provided by operating activities:
net income	-441,118,000	-33,405,000	-22,163,000	37,572,000	-4,931,000	-6,663,000	1,883,000	-40,258,000	84,000	1,644,000	-985,000	-11,840,000	-2,408,000	6,458,000	4,283,000	-3,752,000
adjustments to reconcile net income to net cash (used for)/provided by operating activities:
depreciation and amortization expense	35,782,000	33,901,000	34,035,000	31,376,000	34,600,000	33,586,000	36,752,000	32,007,000	29,196,000	27,939,000	26,479,000	28,127,000	27,814,000	27,841,000	27,350,000	25,663,000
deferred and other income taxes	-20,117,000	-10,668,000	3,089,000	5,316,000	-5,552,000	214,000
goodwill impairment
other asset impairments and lease termination charges
loss/(gain) on disposal of property and equipment	214,000	189,000
loss on divestiture of insomnia cookies
gain on sale-leaseback							0	0	15,000	-9,661,000	-2,238,000	-1,937,000	0	-2,374,000
share-based compensation	4,634,000	2,603,000	10,546,000	9,969,000	7,648,000	6,986,000	6,375,000	7,452,000	4,824,000	5,545,000	4,852,000	2,825,000	5,452,000	5,041,000	5,950,000	6,315,000
change in accounts and notes receivable allowances	784,000	202,000	213,000	106,000	214,000	113,000	150,000	132,000	38,000	334,000	192,000	185,000	349,000	-156,000	142,000	23,000
inventory write-off	647,000	848,000	1,052,000	693,000	627,000	411,000	726,000	278,000	3,129,000	7,115,000	480,000	137,000	0	251,000	1,088,000	2,207,000
amortization related to settlement of interest rate swap derivatives			0	0	-2,955,000	-2,955,000	-2,955,000	-2,955,000
other	999,000	1,225,000	-882,000	-595,000	70,000	788,000	1,589,000	-430,000	1,200,000	-204,000	1,428,000	1,537,000	612,000	-1,345,000	909,000	110,000
change in operating assets and liabilities, excluding foreign currency translation adjustments	-26,052,000	-15,891,000			3,262,000	-50,383,000			10,581,000	-35,190,000
net cash from operating activities	-32,543,000	-20,834,000	27,045,000	3,262,000	33,230,000	-17,705,000	1,512,000	-2,221,000	35,888,000	10,365,000	69,088,000	16,807,000	25,532,000	28,391,000	42,436,000	41,943,000
capex	-28,209,000	-25,897,000	-33,915,000	-26,142,000	-31,671,000	-29,064,000	-32,822,000	-34,315,000	-27,737,000	-26,553,000	-36,715,000	-23,542,000	-22,000,000	-29,460,000	-36,012,000	-30,643,000
free cash flows	-60,752,000	-46,731,000	-6,870,000	-22,880,000	1,559,000	-46,769,000	-31,310,000	-36,536,000	8,151,000	-16,188,000	32,373,000	-6,735,000	3,532,000	-1,069,000	6,424,000	11,300,000
cash flows provided by/(used for) investing activities:
purchase of property and equipment	-28,209,000	-25,897,000	-33,915,000	-26,142,000	-31,671,000	-29,064,000	-32,822,000	-34,315,000	-27,737,000	-26,553,000	-36,715,000	-23,542,000	-22,000,000	-29,460,000	-36,012,000	-30,643,000
proceeds from sale-leaseback							0	0	0	10,025,000	2,701,000	2,700,000	0	3,000,000
purchase of equity method investment			0	0							0
net proceeds from divestiture of insomnia cookies			6,480,000
principal payments received from loans to franchisees													14,000	15,000	25,000	22,000
disbursement for loan receivable			0	0
other investing activities	13,000	86,000		14,000	147,000	19,000		-143,000	81,000	82,000
net cash provided by/(used for) investing activities			-25,465,000
cash flows from financing activities:
proceeds from the issuance of debt	334,400,000	182,500,000	186,250,000	125,000,000	185,500,000	179,500,000	131,000,000	55,500,000	97,500,000	891,698,000	27,500,000	68,500,000	25,000,000	28,000,000	25,000,000	130,000,000
repayment of long-term debt and lease obligations	-370,272,000	-115,622,000	-167,086,000	-238,895,000	-174,454,000	-132,343,000	-119,140,000	-48,670,000	-64,436,000	-852,144,000	-31,001,000	-20,001,000	-21,482,000	-28,697,000	-31,139,000	-574,557,000
payment of financing costs							-175,000	0	0	-5,000,000					0	0
proceeds from structured payables	79,144,000	118,908,000	77,638,000	108,389,000	88,875,000	101,287,000	96,049,000	71,160,000	29,182,000	44,757,000	62,564,000	66,362,000	78,917,000	74,180,000	71,924,000	54,329,000
payments on structured payables	-56,360,000	-142,868,000	-80,981,000	-73,535,000	-93,395,000	-97,416,000	-55,003,000	-32,651,000	-56,440,000	-70,480,000	-82,679,000	-78,248,000	-75,169,000	-58,361,000	-64,562,000	-84,963,000
capital contribution by shareholders, net of loans issued				0	687,000	232,000		0			0	-261,000
distribution to shareholders	-5,973,000	-5,961,000	-5,949,000	-5,936,000	-5,905,000	-5,902,000	-5,901,000	-5,886,000	-5,887,000	-5,884,000	-5,860,000	-5,860,000	-5,855,000	-5,855,000	-5,853,000	-7,970,000
payments for repurchase and retirement of common stock	-664,000	-123,000	-1,123,000	-91,000	-3,471,000	-804,000	-271,000	-1,462,000			-1,594,000	-62,000	-897,000	-1,466,000	-602,000	-35,803,000
distribution to noncontrolling interest	0	-36,000	-6,548,000	-32,889,000	-1,169,000	-977,000	-2,655,000	-1,637,000	-10,107,000	-1,139,000	-196,000	-2,029,000	-8,134,000	-1,362,000	-6,099,000	-11,239,000
net cash from financing activities	-20,550,000	36,798,000				43,577,000		35,429,000							-11,264,000	-3,193,000
effect of exchange rate changes on cash, cash equivalents and restricted cash	-999,000	-301,000	-1,548,000	1,201,000	1,714,000	-1,829,000	862,000	215,000	-1,638,000	-1,373,000	2,999,000	-3,494,000	-2,245,000	-2,228,000	-377,000	-666,000
net decrease in cash, cash equivalents and restricted cash	2,656,000	-10,148,000		-3,224,000	-4,504,000	-5,002,000		-833,000	-3,110,000	-5,646,000
cash, cash equivalents and restricted cash at beginning of period	0	29,315,000		0	0	38,614,000		0	0	35,730,000		0	0	39,192,000		0
cash, cash equivalents and restricted cash at end of period	2,656,000	19,167,000		-3,224,000	-4,504,000	33,612,000		-833,000	-3,110,000	30,084,000		2,292,000	-6,084,000	32,291,000		7,629,000
supplemental schedule of non-cash investing and financing activities:
increase in accrual for property and equipment	5,500,000	4,812,000	1,852,000	186,000				19,980,000				11,773,000	-990,000	5,489,000
accrual for distribution to shareholders		-5,960,000	-9,000	-24,000	-14,000	-5,905,000	-1,000	-15,000	-2,000	-5,884,000	-24,000	0	-5,000	-5,855,000	-1,075,000	2,117,000
reconciliation of cash, cash equivalents and restricted cash at end of period:
cash and cash equivalents	2,542,000	18,722,000	3,552,000	-3,215,000	-4,507,000	33,132,000	12,474,000	-924,000	-3,040,000	29,675,000	7,275,000	2,300,000	-5,819,000	31,615,000	-6,333,000	7,518,000
restricted cash	114,000	445,000	-121,000	-9,000	3,000	480,000	-1,000	91,000	-70,000	409,000	-44,000	-8,000	-265,000	676,000	437,000	111,000
total cash, cash equivalents and restricted cash	2,656,000	19,167,000	3,431,000	-3,224,000	-4,504,000	33,612,000	12,473,000	-833,000	-3,110,000	30,084,000	7,231,000	2,292,000	-6,084,000	32,291,000	-5,896,000	7,629,000
cash flows used for operating activities:
adjustments to reconcile net income to net cash from operating activities:
impairment and lease termination charges		162,000	4,096,000	-80,000	201,000	247,000	17,198,000	-97,000	2,908,000	4,900,000	11,042,000	5,264,000	1,773,000	218,000	2,653,000	-272,000
cash flows used for investing activities:
net cash from investing activities		-25,811,000			-36,116,000	-29,045,000	-34,230,000	-34,256,000	-27,656,000	-16,446,000	-33,773,000	-39,422,000	-21,842,000	-26,437,000	-36,691,000	-30,455,000
cash flows from operating activities:
adjustments to reconcile net income/(loss) to net cash from operating activities:
loss on extinguishment of debt							0	0	0	472,000					0	0
loss on disposal of property and equipment										33,000				24,000	301,000
gain on divestiture of insomnia cookies			-3,327,000
gain on remeasurement of equity method investment			0
settlement of interest rate swap derivatives							0	0	0	7,657,000
change in operating assets and liabilities, excluding business acquisitions and divestitures, and foreign currency translation adjustments:
accounts, notes, and taxes receivable
inventories
other current and noncurrent assets
operating lease assets and liabilities
accounts payable and accrued liabilities
other long-term obligations and deferred credits
proceeds from disposals of assets							16,000				221,000	-16,000	864,000	8,000	16,000	55,000
acquisition of shops and franchise rights from franchisees, net of cash acquired			-5,326,000								5,000				-12,442,000	0
principal payment received from loan to insomnia cookies			0
cash flows (used for)/provided by financing activities:
payment of contingent consideration related to a business combination							0				0	0	0	-900,000
capital contribution from shareholders, net of loans issued
payments of issuance costs in connection with initial public offering
proceeds from sale of noncontrolling interest in subsidiary			1,198,000								183,000	0	358,000	52,000	67,000	81,000
net cash (used for)/provided by financing activities			3,399,000										-7,529,000	-6,627,000
net (decrease)/increase in cash, cash equivalents and restricted cash											7,231,000			-6,901,000
cash, cash equivalents and restricted cash at beginning of the fiscal year
cash, cash equivalents and restricted cash at end of the fiscal year
stock issuance under shareholder notes											67,000	223,000	133,000	191,000	517,000	0
reconciliation of cash, cash equivalents and restricted cash at end of fiscal year:
note 1
note 2
note 3
note 4
note 5
note 6
note 7
note 8
note 9
note 10
note 11
note 12
note 13
note 14
note 15
note 16
note 17
note 18
note 19
note 20
change in operating assets and liabilities, excluding business acquisitions and divestitures, and foreign currency translation adjustments
adjustments to reconcile net (loss)/income to net cash from operating activities:
gain on disposal of property and equipment								-17,000
cash flows from/(used for) financing activities:
net cash provided by/(used for) financing activities										1,808,000
cash flows (used for)/from operating activities:
adjustments to reconcile net (loss)/income to net cash (used for)/provided by operating activities:
(gain)/loss on disposal of property and equipment						-49,000						255,000
increase/(decrease) in accrual for property and equipment						3,913,000
change in operating assets and liabilities, excluding business acquisitions and foreign currency translation adjustments:
maturities of held-to-maturity debt securities															631,000	111,000
proceeds from ipo, net of underwriting discounts															0
payments of issuance costs in connection with ipo											0	0	0	-12,458,000
net increase/(decrease) in cash, cash equivalents and restricted cash
deferred income taxes								24,377,000	-11,524,000	-219,000		-3,393,000	-6,044,000	-822,000	-12,664,000	1,173,000
change in operating assets and liabilities, excluding business acquisitions and foreign currency translation adjustments												-4,353,000	-1,493,000	-6,745,000
cash flows used for financing activities:
capital contribution by shareholders														240,000	0	-400,000
(decrease)/increase in accrual for property and equipment										-104,000
gain on contingent consideration related to a business combination
purchases of held-to-maturity debt securities
cash flows (used for)/from financing activities:
accrual for repurchase and retirement of common stock																35,615,000
accrual for distribution to noncontrolling interest
common stock issuance under subscription receivable in connection with initial public offering, net of underwriting discounts and issuance costs
payment of contingent consideration in excess of acquisition date fair value
collection of related party income tax receivable
contingent consideration incurred for acquisition of krispy kreme mexico
contingent consideration incurred for acquisition of shops and franchise rights from domestic franchisees
net increase in cash, cash equivalents and restricted cash
accrual for property and equipment																1,756,000

We provide you with 20 years of cash flow statements for Krispy Kreme stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Krispy Kreme stock. Explore the full financial landscape of Krispy Kreme stock with our expertly curated income statements.

The information provided in this report about Krispy Kreme stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.